All Stories

  1. Influenza Vaccine Effectiveness Against Mild and Severe Outcomes: A Comparison Study in Portugal
  2. Distribution of the West Nile Virus vector, Culex pipiens, in mainland Portugal: a geospatial modelling study
  3. A protocol for high-dose quadrivalent influenza vaccine effectiveness in the community and long-term care facilities using electronic health records
  4. Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study
  5. Unmeasured confounding and misclassification in vaccine effectiveness studies using electronic health records (EHRs): an evaluation of a multi country European study (VEBIS-EHR)
  6. Spatial analysis of HPV infection and contextual factors associated with higher HPV prevalence
  7. Long term bivalent mRNA vaccine effectiveness against COVID-19 hospitalisations and deaths in Portugal: a cohort study based on electronic health records
  8. COVID-19 vaccine effectiveness in the paediatric population aged 5–17 years: a multicentre cohort study using electronic health registries in six European countries, 2021 to 2022
  9. Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23
  10. Self-Perceived Decline in Memory and Concentration 9 and 12 months post COVID-19 infection
  11. Adapting to COVID-19: Insights from Portuguese residents’ home-based life
  12. Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study
  13. A protocol for high-dose quadrivalent influenza vaccine effectiveness in the community and long-term care facilities using electronic health records
  14. Correction: Long COVID is not the same for everyone: a hierarchical cluster analysis of long COVID symptoms 9 and 12 months after SARS-CoV-2 test
  15. Toscana Virus in Wild-Caught Sand Flies in Portugal, Findings from the National Vector Surveillance Network, 2023
  16. Long COVID is not the same for everyone: a hierarchical cluster analysis of Long COVID symptoms 9 and 12 months after SARS-CoV-2 test
  17. The spread of the invasive mosquito Aedes albopictus (Diptera: Culicidae) in Portugal: a first genetic analysis
  18. Mark–Release–Recapture Trial with Aedes albopictus (Diptera, Culicidae) Irradiated Males: Population Parameters and Climatic Factors
  19. Individual risk factors associated with SARS-CoV-2 infection during Alpha variant in high-income countries: a systematic review and meta-analysis
  20. Mark-Release-Recapture Trial with <em>Aedes albopictus</em> (Diptera, Culicidae) Irradiated Males and the Influence of Climatic Factors
  21. Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR Network Study
  22. The spread of the invasive mosquito Aedes albopictus (Diptera: Culicidae) in Portugal: a first genetic analysis
  23. Effectiveness of XBB.1.5 monovalent COVID-19 vaccines during a period of XBB.1.5 dominance in EU/EEA countries, October to November 2023
  24. Is a tiered restrictions system an effective intervention for COVID-19 control? Results from Portugal, November-December 2020
  25. Effectiveness of XBB.1.5 Monovalent COVID‐19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS‐EHR Network Study
  26. Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023
  27. Children with asthma and eczema carrying filaggrin loss‐of‐function mutations have increased antibiotic use through to adulthood
  28. Investigating the role of symptom valorisation in tuberculosis patient delay in urban areas in Portugal
  29. Does CDHR3 gene polymorphism affect paediatric asthma and its treatment response?
  30. Bivalent mRNA vaccine effectiveness against COVID-19 infections, hospitalisations and deaths in Portugal: a cohort study based on electronic health records, September 2022 to May 2023
  31. The effect of TB patient delay on loss to follow-up in Portugal
  32. LOCUS (LOng Covid–Understanding Symptoms, events and use of services in Portugal): A three-component study protocol
  33. Effect of the COVID‐19 pandemic on the frequency of emergency department visits in Portugal: An interrupted time series analysis until July 2021
  34. The Pandemic-Related Factors Associated with Emergency Department Visits in Portugal throughout Two Years of the Pandemic: A Retrospective Population-Based Study
  35. A temporal analysis on patient and health service delays in pulmonary tuberculosis in Portugal: inter and intra‑regional differences and in(equalities) between gender and age
  36. Ecological factors associated with areas of high tuberculosis diagnosis delay
  37. Association between perception of COVID-19 risk, confidence in health services and avoidance of emergency department visits: results from a community-based survey in Portugal
  38. Non-adherence to COVID-19 lockdown: who are they? A cross-sectional study in Portugal
  39. Rehabilitation Program in Otolaryngology Unity
  40. Vitamin D levels in Portuguese military personnel
  41. Factors Associated with COVID-19 Vaccine Hesitancy after Implementation of a Mass Vaccination Campaign
  42. Multi-Drug and β-Lactam Resistance in Escherichia coli and Food-Borne Pathogens from Animals and Food in Portugal, 2014–2019
  43. Physical Distancing and Mental Well-Being in Youth Population of Portugal and Brazil during the COVID-19 Pandemic
  44. Rehabilitation Nursing Program in Oncological Surgery of the Head and Neck: A Retrospective Cohort Study
  45. Factors Associated with the Patient’s Decision to Avoid Healthcare during the COVID-19 Pandemic
  46. Patient and healthcare delays in critical and non-critical pulmonary tuberculosis incidence areas in Portugal: are there differences?
  47. Delayed diagnosis of active pulmonary tuberculosis - potential risk factors for patient and healthcare delays in Portugal
  48. A Case-Control Study of Contextual Factors for SARS-CoV-2 Transmission
  49. Tuberculosis amongst foreign-born and nationals: different delays, different risk factors
  50. Predicting Independence 6 and 18 Months after Ischemic Stroke Considering Differences in 12 Countries: A Secondary Analysis of the IST-3 Trial
  51. ADRB2 Haplotypes and Asthma Exacerbations in Children and Young Adults: An Individual Participant Data Meta‐Analysis
  52. An FCER2 polymorphism is associated with increased oral leukotriene receptor antagonist and allergic rhinitis prescribing
  53. Factors Associated with COVID-19 Vaccine Hesitancy
  54. Evolution of inequalities in the coronavirus pandemics in Portugal: an ecological study
  55. COVID-19 Barometer: Social Opinion – What Do the Portuguese Think in This Time of COVID-19?
  56. A large collaboration identifies biomarkers of the response to inhaled corticosteroids in asthma
  57. Monitoring real‐life utilization of pembrolizumab in advanced melanoma using the Portuguese National Cancer Registry
  58. Real‐world effectiveness of pembrolizumab in previously treated non‐small cell lung cancer: A population‐based cohort study
  59. The Association of Chronic Diseases with COVID-19 Outcomes and its Role on Risk Perception: Nationwide COVID-19 Database & Online Community-Based Survey (Preprint)
  60. The Association Between Chronic Disease and Serious COVID-19 Outcomes and Its Influence on Risk Perception: Survey Study and Database Analysis (Preprint)
  61. Insights into tuberculosis: A survival analysis of time to recurrence in Portugal, between 2002 and 2009
  62. The Demand for Hospital Emergency Services: Trends during the First Month of COVID-19 Response
  63. Inpatient Hospitalizations during the First Wave of COVID-19 in Portugal
  64. COVID-19 Transmission Dynamics: A Space-and-Time Approach
  65. Genome-wide association study of inhaled corticosteroid response in admixed children with asthma
  66. 17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use
  67. Individuals with filaggrin-related eczema and asthma have increased long-term medication and hospital admission costs
  68. Early life antibiotic use and the risk of asthma and asthma exacerbations in children
  69. SNP typing reveals similarity in Mycobacterium tuberculosis genetic diversity between Portugal and Northeast Brazil
  70. inTB - a data integration platform for molecular and clinical epidemiological analysis of tuberculosis